The Selective Serotonin Reuptake Inhibitor Fluoxetine Directly Inhibits Osteoblast Differentiation and Mineralization During Fracture Healing in Mice

被引:59
作者
Bradaschia-Correa, Vivian [1 ]
Josephson, Anne M. [1 ]
Mehta, Devan [1 ]
Mizrahi, Matthew [1 ]
Neibart, Shane S. [1 ]
Liu, Chao [1 ,2 ]
Kennedy, Oran D. [1 ,2 ]
Castillo, Alesha B. [1 ,2 ]
Egol, Kenneth A. [1 ]
Leucht, Philipp [1 ,3 ]
机构
[1] NYU, Dept Orthopaed Surg, Hosp Joint Dis, Langone Med Ctr, New York, NY USA
[2] NYU, Dept Mech & Aerosp Engn, Tandon Sch Engn, New York, NY USA
[3] NYU, Sch Med, Dept Cell Biol, 550 First Ave,MSB 617, New York, NY 10016 USA
关键词
OSTEOPOROSIS; DEPRESSION; OSTEOBLAST; OSTEOPROGENITOR CELL; BONE; BONE MASS; 5-HYDROXYTRYPTAMINE; ANTIDEPRESSANTS; REGENERATION; MEDICATIONS; EXPRESSION; DEPRESSION; ORIGIN; COHORT; US;
D O I
10.1002/jbmr.3045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic use of selective serotonin reuptake inhibitors (SSRIs) for the treatment of depression has been linked to osteoporosis. In this study, we investigated the effect of chronic SSRI use on fracture healing in two murine models of bone regeneration. First, we performed a comprehensive analysis of endochondral bone healing in a femur fracture model. C57/BL6 mice treated with fluoxetine, the most commonly prescribed SSRI, developed a normal cartilaginous soft-callus at 14 days after fracture and demonstrated a significantly smaller and biomechanically weaker bony hard-callus at 28 days. In order to further dissect the mechanism that resulted in a smaller bony regenerate, we used an intramembranous model of bone healing and revealed that fluoxetine treatment resulted in a significantly smaller bony callus at 7 and 14 days postinjury. In order to test whether the smaller bony regenerate following fluoxetine treatment was caused by an inhibition of osteogenic differentiation and/or mineralization, we employed in vitro experiments, which established that fluoxetine treatment decreases osteogenic differentiation and mineralization and that this effect is serotonin-independent. Finally, in a translational approach, we tested whether cessation of the medication would result in restoration of the regenerative potential. However, histologic and CT analysis revealed non-union formation in these animals with fibrous tissue interposition within the callus. In conclusion, fluoxetine exerts a direct, inhibitory effect on osteoblast differentiation and mineralization, shown in two disparate murine models of bone repair. Discontinuation of the drug did not result in restoration of the healing potential, but rather led to complete arrest of the repair process. Besides the well-established effect of SSRIs on bone homeostasis, our study provides strong evidence that fluoxetine use negatively impacts fracture healing. (c) 2017 American Society for Bone and Mineral Research.
引用
收藏
页码:821 / 833
页数:13
相关论文
共 28 条
[1]   Platelet serotonin transporter (5HTt): physiological influences on kinetic characteristics in a large human population [J].
Banovic, Miroslav ;
Bordukalo-Niksic, Tatjana ;
Balija, Melita ;
Cicin-Sain, Lipa ;
Jernej, Branimir .
PLATELETS, 2010, 21 (06) :429-438
[2]   Neurotransmitter action in osteoblasts: Expression of a functional system for serotonin receptor activation and reuptake [J].
Bliziotes, MM ;
Eshleman, AJ ;
Zhang, XW ;
Wiren, KM .
BONE, 2001, 29 (05) :477-486
[3]   Long-term sequestration of fluorinated compounds in tissues after fluvoxamine or fluoxetine treatment:: a fluorine magnetic resonance spectroscopy study in vivo [J].
Bolo, NR ;
Hodé, Y ;
Macher, JP .
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE, 2004, 16 (06) :268-276
[4]  
BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115
[5]   The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation [J].
Collet, C. ;
Schiltz, C. ;
Geoffroy, V. ;
Maroteaux, L. ;
Launay, J. -M. ;
de Vernejoul, M. -C. .
FASEB JOURNAL, 2008, 22 (02) :418-427
[6]   Selective Serotonin Reuptake Inhibitor Exposure Alters Osteoblast Gene Expression and Craniofacial Development in Mice [J].
Cray, James J., Jr. ;
Weinberg, Seth M. ;
Parsons, Trish E. ;
Howie, R. Nicole ;
Elsalanty, Mohammed ;
Yu, Jack C. .
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2014, 100 (12) :912-923
[7]   Effects of chronic fluoxetine in animal models of anxiety and depression [J].
Dulawa, SC ;
Hollick, KA ;
Gundersen, B ;
Hen, R .
NEUROPSYCHOPHARMACOLOGY, 2004, 29 (07) :1321-1330
[8]   Effects of Depression and Serotonergic Antidepressants on Bone: Mechanisms and Implications for the Treatment of Depression [J].
Fernandes, Brisa S. ;
Hodge, Jason M. ;
Pasco, Julie A. ;
Berk, Michael ;
Williams, Lana J. .
DRUGS & AGING, 2016, 33 (01) :21-25
[9]   Use of selective serotonin reuptake inhibitors and bone mass in adolescents: An NHANES study [J].
Feuer, Alexis J. ;
Demmer, Ryan T. ;
Thai, Ashley ;
Vogiatzi, Maria G. .
BONE, 2015, 78 :28-33
[10]   Jagged1 is essential for osteoblast development during maxillary ossification [J].
Hill, Cynthia R. ;
Yuasa, Masato ;
Schoenecker, Jonathan ;
Goudy, Steven L. .
BONE, 2014, 62 :10-21